ASCCP Management Guidelines
77
Quality Score
Strong
ASCCP Management Guidelines
Medium confidence
✍️ bumetric analysis
“
ASCCP Management Guidelines is an iOS app from American Society for Colposcopy and Cervical Pathology Inc in the Medical category, currently rated 4.8★ across 8,337 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 77: Strong (healthy traction). For a Medical app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$15.8K
per month
→
12-mo forecast
$16.4K – $34.3K
per month
→
24-mo forecast
$20.3K – $60.9K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$80K
↳ What it cost to build · not monthly revenue
Likely range $60K – $110K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~4 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Medical complexity ×1.55 | +$27K |
Total estimate
$80K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$400K
↳ What it would sell for · not monthly revenue
Marketplace range $300K – $500K · 19× MRR multiple
💸
~5.0× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Medical category multiple | +12% |
Final multiple
19× MRR
👥 Estimated audience size
455K
Lifetime downloads (US-equivalent)
Monthly active
110K
Daily active
22K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
DAU / MAU
20% sticky
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$15.8K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$15.0K – $25.1K
12 months
$16.4K – $34.3K
24 months
$20.3K – $60.9K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 49/100MID TIERunderperforming peersGrowth Velocity
5.0
Founder Strength
5.3
Product Quality
8.6
Revenue Strength
4.2
Monetization Maturity
1.0
Defensibility
3.5
Market Position
2.0
Operational Safety
10.0
- 💰 Revenue: Modest — $11K - $23K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.77★ across 8,337 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $285K-$507K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 7 of 7 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| Excellent rating (4.8★)METRIC | +$2,200 | |
| 5 starREVIEW | +$1,800 | |
| Low install base (8,337 ratings)METRIC | +$1,500 | |
| priceyREVIEW | −$800 | |
| Established app (6y old)METRIC | +$800 | |
| Single-language (English only)METRIC | −$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v2.4.1
Incorporates HPV Self-Collection Recommendations
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- ASCCP Management Guidelines
- Developer
- American Society for Colposcopy and Cervical Pathology Inc
- Bundle ID
- org.asccp.app2019
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Shaping the Future of Cervical Cancer Prevention
- Description
- Since 1964, ASCCP has advanced cervical cancer prevention and HPV management through research, education, and clinical guidance.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $20.1K/mo
- Top-grossing rank
- 🇺🇸#81 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
- Name
- Not found
- X / Twitter
- twitter.com/ASCCP
- linkedin.com/company/asccp
- GitHub
- Not found
- X followers
- Not found
- Public statements
- Not found
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
- Socials
- facebook facebook.com/ASCCP · instagram instagram.com/asccp1 · linkedin linkedin.com/company/asccp · twitter twitter.com/ASCCP
- info@asccp.org
- Phone
- 301-857-7877
- Contact page
- Not found
- About page
- asccp.org/about/about-overview
📈Ratings growth8,337 ratings+13795% lifetimeShow 3-year history estimate ▾
Tracked (44 weeks) Pre-tracking estimate (34 weeks) · model-based, ±5% noise · anchored to release date and current value
🗺️Geographic Distribution1 of 9 markets
🇺🇸
US
Top-grossing rank: #81 / 100
Other markets
Outside top 100
in US, GB, DE, FR, JP, CA, AU, BR, IN
in US, GB, DE, FR, JP, CA, AU, BR, IN
This app currently ranks in only one of the 9 markets we monitor. Niche or regional apps often launch this way before global rollout. Rankings update daily.
📊Category Rank Trajectory#81 now · best #74 · worst #100
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
💰Pricing History$0.00 → $14.99 (+0%)
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.… View full description on the official store →
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 47 MB🔞 17+📱 iOS 11.2+🔖 v2.4.1🔄 updated 0d ago🌐 EN📂 Medical💰 Paid
📅
What Worked™ · Development Pipeline
8 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
💲
Went paid — introduced $14.99 price point
2026-03
⭐
Rating ↑ 2.54 → 5.00 (improved 2.46★)
2026-03
📈
Crossed 100 ratings — social-proof flywheel kicking in
2021-09
📈
Crossed 50 ratings — social-proof flywheel kicking in
2020-06
📈
Crossed 10 ratings — social-proof flywheel kicking in
2020-06
⭐
Rating ↑ 3.33 → 3.75 (improved 0.42★)
2020-06
🚀
First tracked snapshot — initial data captured
2020-06
⭐
Rating ↑ 1.00 → 3.00 (improved 2.00★)
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 5★ | 1 | 5★ this version |
| 🇧🇷 BR | 4.8★ | 40 | 4.8★ this version |
| 🇨🇦 CA | 4.95238★ | 21 | 4.95238★ this version |
| 🇩🇪 DE | 5★ | 2 | 5★ this version |
| 🇫🇷 FR | 4.33333★ | 3 | 4.33333★ this version |
| 🇬🇧 GB | 5★ | 6 | 5★ this version |
| 🇮🇳 IN | 5★ | 2 | 5★ this version |
| 🇯🇵 JP | 5★ | 1 | 5★ this version |
| 🇺🇸 US | 4.77091★ | 8,394 | 4.77091★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for ASCCP Management Guidelines: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
About this analysis
Why medium confidence: 8,337 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does ASCCP Management Guidelines make per month?▴
Based on our ML-calibrated revenue forecast, ASCCP Management Guidelines earns approximately $20K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like ASCCP Management Guidelines?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes ASCCP Management Guidelines?▴
ASCCP Management Guidelines is published by American Society for Colposcopy and Cervical Pathology Inc on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is ASCCP Management Guidelines's BU Score?▴
ASCCP Management Guidelines has a BU Score of 77/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.